Buspirone Hydrochloride/Melatonin

盐酸丁螺环酮/褪黑素

Report date: 2022/07/04 19:38:02

Base Information

Drug NameBuspirone Hydrochloride/Melatonin
Drug Alias NameBuspirone Hydrochloride and Melatonin盐酸丁螺环酮褪黑素Melatonin and Buspirone Hydrochloride褪黑素盐酸丁螺环酮褪黑素盐酸丁/螺环酮 +[7] 
ClassificationSmall molecules
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor partial agonistsMelatonin receptor agonistsDopamine D2 receptor antagonists
TargetsSerotonin 1a (5-HT1a) receptorDopamine D2 receptorMelatonin receptor
Therapy Area/IndicationsDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes Buspirone HydrochlorideMelatonin
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBraincells Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBraincells Inc
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, Major

Other Information

ATC CodeN/A
Related LinksN/A